Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 212

1.

[A Case of Ureteral Sciatic Hernia Treated with Ureteral Stent].

Hattori Y, Hida T, Nakamura K, Takahashi T, Mitsumori K, Ohnishi H.

Hinyokika Kiyo. 2019 Jul;65(7):295-298. doi: 10.14989/ActaUrolJap_65_7_295. Japanese.

PMID:
31501395
2.

Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study.

Takahashi T, Usuki K, Matsue K, Ohno H, Sakura T, Imanaka R, Murakami M, Ohwada S, Takagi T, Sakajiri S.

Int J Hematol. 2019 Dec;110(6):665-674. doi: 10.1007/s12185-019-02727-6. Epub 2019 Aug 31.

PMID:
31473943
3.

Overall survival is the primary endpoint in a trial of neoadjuvant chemotherapy for bladder cancer?

Takahashi T.

Cancer. 2019 Nov 15;125(22):4105-4106. doi: 10.1002/cncr.32415. Epub 2019 Jul 29. No abstract available.

PMID:
31355910
4.

Exacerbation of pathogenic Th17-cell-mediated cutaneous graft-versus-host-disease in human IL-1β and IL-23 transgenic humanized mice.

Ito R, Katano I, Otsuka I, Hanazawa A, Takahashi T, Kawai K, Yagoto M, Goto M, Ogura T, Takahashi R, Ito M.

Biochem Biophys Res Commun. 2019 Aug 20;516(2):480-485. doi: 10.1016/j.bbrc.2019.06.094. Epub 2019 Jun 20.

PMID:
31230747
5.

Recent Advances in Allergy Research Using Humanized Mice.

Ito R, Maruoka S, Gon Y, Katano I, Takahashi T, Ito M, Izuhara K, Nunomura S.

Int J Mol Sci. 2019 Jun 4;20(11). pii: E2740. doi: 10.3390/ijms20112740. Review.

7.

Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).

Murakami H, Kasamatsu T, Murakami J, Kiguchi T, Kanematsu T, Ogawa D, Takamatsu H, Handa H, Ozaki S, Miki H, Takahashi T, Takeo T, Yamauchi T, Morishita T, Kosugi H, Shimizu K.

Int J Hematol. 2019 Jul;110(1):125-126. doi: 10.1007/s12185-019-02663-5.

PMID:
31119612
8.

Mogamulizumab Treatment Elicits Autoantibodies Attacking the Skin in Patients with Adult T-Cell Leukemia-Lymphoma.

Suzuki Y, Saito M, Ishii T, Urakawa I, Matsumoto A, Masaki A, Ito A, Kusumoto S, Suzuki S, Hiura M, Takahashi T, Morita A, Inagaki H, Iida S, Ishida T.

Clin Cancer Res. 2019 Jul 15;25(14):4388-4399. doi: 10.1158/1078-0432.CCR-18-2575. Epub 2019 Apr 24.

PMID:
31018922
9.
10.

Safety and effectiveness of mogamulizumab in relapsed or refractory adult T-cell leukemia-lymphoma.

Ishitsuka K, Yurimoto S, Tsuji Y, Iwabuchi M, Takahashi T, Tobinai K.

Eur J Haematol. 2019 May;102(5):407-415. doi: 10.1111/ejh.13220. Epub 2019 Mar 12.

11.

Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).

Murakami H, Kasamatsu T, Murakami J, Kiguchi T, Kanematsu T, Ogawa D, Takamatsu H, Handa H, Ozaki S, Miki H, Takahashi T, Takeo T, Yamauchi T, Morishita T, Kosugi H, Shimizu K.

Int J Hematol. 2019 Apr;109(4):409-417. doi: 10.1007/s12185-019-02607-z. Epub 2019 Jan 31. Erratum in: Int J Hematol. 2019 Jul;110(1):125-126.

PMID:
30701467
12.

An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome.

Endo S, Shimazaki R; Antithrombin Gamma Study Group.

J Intensive Care. 2018 Nov 16;6:75. doi: 10.1186/s40560-018-0339-z. eCollection 2018.

13.

A humanized mouse model to study asthmatic airway inflammation via the human IL-33/IL-13 axis.

Ito R, Maruoka S, Soda K, Katano I, Kawai K, Yagoto M, Hanazawa A, Takahashi T, Ogura T, Goto M, Takahashi R, Toyoshima S, Okayama Y, Izuhara K, Gon Y, Hashimoto S, Ito M, Nunomura S.

JCI Insight. 2018 Nov 2;3(21). pii: 121580. doi: 10.1172/jci.insight.121580.

14.

[Right Essential Renal Hematuria that Can Not Be Coagulated with a Ureteroscope Treated by Hydrogen Peroxide Instillation : A Case Report].

Hida T, Hattori Y, Nakamura K, Kohno J, Okubo K, Takahashi T, Mitsumori K, Nishimura K, Ohnishi H.

Hinyokika Kiyo. 2018 Aug;64(8):335-338. doi: 10.14989/ActaUrolJap_64_8_335. Review. Japanese.

15.

Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease.

Ota M, Matsuo J, Ishida I, Takano H, Yokoi Y, Hori H, Yoshida S, Ashida K, Nakamura K, Takahashi T, Kunugi H.

Neurosci Lett. 2019 Jan 18;690:232-236. doi: 10.1016/j.neulet.2018.10.048. Epub 2018 Oct 24.

16.

Immunological responses against hepatitis B virus in human peripheral blood mononuclear cell-engrafted mice.

Aono S, Tatsumi T, Yoshioka T, Tawara S, Nishio A, Onishi Y, Fukutomi K, Nakabori T, Kodama T, Shigekawa M, Hikita H, Sakamori R, Takahashi T, Suemizu H, Takehara T.

Biochem Biophys Res Commun. 2018 Sep 10;503(3):1457-1464. doi: 10.1016/j.bbrc.2018.07.063. Epub 2018 Jul 20.

PMID:
30033102
17.

R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.

Hara T, Yoshikawa T, Goto H, Sawada M, Yamada T, Fukuno K, Kasahara S, Shibata Y, Matsumoto T, Mabuchi R, Nakamura N, Nakamura H, Ninomiya S, Kitagawa J, Kanemura N, Nannya Y, Katsumura N, Takahashi T, Kito Y, Takami T, Miyazaki T, Takeuchi T, Shimizu M, Tsurumi H.

Hematol Oncol. 2018 Oct;36(4):638-644. doi: 10.1002/hon.2524. Epub 2018 Jun 8.

PMID:
29882279
18.

Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study.

Mizuta S, Sawa M, Tsurumi H, Matsumoto K, Miyao K, Hara T, Takahashi T, Sakemura R, Kojima H, Kohno A, Oba MS, Morita S, Sakamoto J, Emi N.

Int J Clin Oncol. 2018 Oct;23(5):980-988. doi: 10.1007/s10147-018-1300-9. Epub 2018 May 29.

19.

Effect of starting oral intake on weekends on the clinical course of patients with aspiration pneumonia.

Kenzaka T, Kumabe A, Kosami K, Ueda Y, Takahashi T, Yamamoto Y, Hayashi Y, Kitao A, Okayama M.

Clin Interv Aging. 2018 May 9;13:895-901. doi: 10.2147/CIA.S161786. eCollection 2018.

20.

Venous Thromboembolism Caused by Spending a Night in a Vehicle After an Earthquake (Night in a Vehicle After the 2016 Kumamoto Earthquake).

Sueta D, Hokimoto S, Hashimoto Y, Sakamoto K, Hosokawa H, Nishigami K, Sato K, Fujisue K, Kojima S, Takahashi T, Hanzawa K, Ogawa H, Tsujita K; Kumamoto Earthquake Thrombosis and Embolism Protection (KEEP) Project Investigators.

Can J Cardiol. 2018 Jun;34(6):813.e9-813.e10. doi: 10.1016/j.cjca.2018.01.014. Epub 2018 May 3. No abstract available. Erratum in: Can J Cardiol. 2018 Oct;34(10):1368.

PMID:
29729882

Supplemental Content

Loading ...
Support Center